Three upcoming Supreme Court decisions have the potential to radically change FDA regulation of medications. The cases, which involve “Chevron deference” and the abortion pill mifepristone, were discussed on a panel during the BIO conference in San Diego.
Though the case started small, it has gained national attention and more than a dozen states have submitted an amicus brief in support of the Health and Hospital Corporation that operates 78 nursing facilities across Indiana.
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
State bans would mean sensitive patient data, such as interactions with a telehealth provider to obtain abortion drugs, could be used against someone as a threat. One expert warned that the value of such data will "skyrocket."
A D.C. appeals court has granted CareFirst's request to file an appeal with the Supreme Court. "[T]he Supreme Court has yet to examine the issue of standing in the context of a data breach case," the health insurer noted in its motion.
Anthem just doesn't want to give up. The insurer has filed a petition with the U.S. Supreme Court seeking review of the Cigna deal.
Also, out-of-pocket costs per hospitalization soar, AstraZeneca seeks to extend Crestor patent under the Orphan Drug Act and Virginia Mason's CEO decides to stay after all.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
Also, CDC approves trial of experimental Zika vaccine, Circassia Pharmaceuticals' cat allergy treatment fails and AI helps reduce misdiagnosis of breast cancer.
Plus, Humana basing executive bonuses on member health, CMS adding thousands of new ICD-10 codes and the CRISPR patent fight is heating up.
“Congress passed the Affordable Care Act to improve health insurance markets, not to destroy them,” wrote Chief Justice John Roberts.
In the wake of the Supreme Court's decision to uphold federal subsidies for health insurance under the Affordable Care Act, Pennsylvania no longer will be establishing its own, state-run exchange, Gov. Tom Wolf said Thursday.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
President Obama's opinion about the Supreme Court taking on King v. Burwell is made clear.
Even people not getting subsidies could be indirectly affected by a Supreme Court ruling against the administration because of the likelihood the decision would roil the insurance risk pool.
An estimated 7.5 million people in 34 states are at risk for losing health insurance subsidies if the Supreme Court rules in favor of the plaintiffs in King v. Burwell this June.
Express Scripts, a prescription drug benefit manager, is seeking payment deals with pharma companies that would set drug prices based on how well their cancer treatments work.
The Supreme Court’s decision last week that some for-profit corporations don’t have to comply with the contraceptive coverage mandate under the Affordable Care Act may have raised more questions than it answered. Expect confusion – and arguments – as lower court judges and the Supreme Court itself apply the decision to other cases. This became […]